PTC CLINIC
Informace pro odborníky

Reference:

1. www.svod.cz
2. ABRAHÁMOVÁ J. a kol. Co byste měli vědět o rakovině prsu, Grada Publishing, 2019, p.30-31, 88-91.
3. Kubeš, J., Pasztorová, A., Andrlík, M. Protonová terapie v léčbě karcinomu prsu.
4. WANG H, WEI J, Zheng Q et al. Radiation-induced heart disease: a review of classification, mechanism and prevention. Int J Biol Sci 2019, 15(10):2128-2138. Doi10.7150/ijbs.35460.
5. HARRIS, ELEANOR E, CANDACE CORREA, et al. Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Pacients After Breast-Conservation Treatment. J Clin Oncol, 2006, 24, p.4100-4106.
6. DARBY, SC., EWERTZ, M., MCGALE, P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 2013, 368, p. 987–998. doi:10.1056/NEJMoa1209825
7. JACOBSE, JN, DUANE, FK, BOEKEL, NB, et al. Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors. Int J Radiat Oncol Biol Phys. 2019;103(3):595–604. doi:10.1016/j.ijrobp.2018.10.025
8. REHAMMAR, JC., JENSEN, MB., MCGALE, P., et al. Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19464 breast cancer patients in Denmark, 1977–2005. Radiother Oncol, 2017, 1232, p. 299–305.
9. VIRMANI, R., FARB, A., CARTER, AJ., JONES, RM. Pathology of radiation-induced coronary artery disease in human and pig. Cardiovasc Radiat Med, 1999, 1, p. 98–101.
10. STOVALL, M, SMITH, SA, LANGHOLZ, BM, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021–1030. doi:10.1016/j.ijrobp.2008.02.040
11. GRANTAZAU, T, OVERGAARD, J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114(1):56–65. doi:10.1016/j.radonc.2014.10.004
12. VOGEL, J, et at. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy. Int J Radiat Oncol Biol Phys, 2017, 99, p.427-423
13. ARES, C, KHAN S, MACARTAIN,AM, et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?. Int J Radiat Oncol Biol Phys. 2010;76(3):685–697. doi:10.1016/j.ijrobp.2009.02.062
14. McDONALD, M., PATEL, SA., HYCKEY, S., et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(3):484–490. doi:10.1016/j.ijrobp.2013.01.038
15. WÖCKEL A, FESTL J, STUBER T, et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2018;78(11):1056‐1088. doi:10.1055/a-0646-4630
16. FONTANILLA, HP, WOODWARD, WA, LINDBERG, ME, et al. Current clinical coverage of Radiation Therapy Oncology Group-defined target volumes for postmastectomy radiation therapy. Pract Radiat Oncol. 2012;2(3):201–209. doi:10.1016/j.prro.2011.10.001
17. PIROTH, MD, BAUMANN, R, BUDACH,W, et al. Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention. Kardiale Toxizität durch Strahlentherapie bei Brustkrebs : Aktuelle Ergebnisse, Bewertung und Prävention. Strahlenther Onkol. 2019;195(1):1–12. doi:10.1007/s00066-018-1378-z
18. ClinicalTrials.gov [online] [cit. 10.4.2020]. Dostupné z: https://clinicaltrials.gov/ct2/show/NCT01766297
19. VERMA, V., IFTEKARUDDIN, Z., BADAR, N., et al. Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer. Radiother Oncol, 2017, 123(2):294–298. doi:10.1016/j.radonc.2017.04.007
20. CUARON, J., CHON, B., TSAI, H., et al. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys, 2015, 92, p. 284–291.
21. KAMMERER, E, GUEVELOU, JL, CHAIKH, A, et al. Proton therapy for locally advanced breast cancer: A systematic review of the literature. Cancer Treat Rev. 2018;63:19–27. doi:10.1016/j.ctrv.2017.11.006
22. LUO, L, CUARON, J, BRAUNSTEIN, L, et al. Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy. Radiother Oncol. 2019;132:250‐256. doi:10.1016/j.radonc.2018.10.002
23. BUSH, DA., DO, S., LUM, S. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes. Int J Radiat Oncol Biol Phys, 2014, 90, p. 501–505.
24. GALLAND, GS., PASHTAN, I., MACDONALD, SM. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial. Int J Radiat Oncol Biol Phys, 2014, 90, p. 493–500.
25. CHANG, JH., LEE, NK., KIM, JY., et al. Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol, 2013, 108, p. 209–214.
26. HERMANDEZ, M., ZHANG, R., SANDERS, M., et al. A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy. J Proton Ther. 2015;1(1):119. doi:10.14319/jpt.11.9
27. JOHANSON, J., ISACSSON, U., LINDMAN, H., et al. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol J Eur Soc Ther Radiol Oncol, 2002, 65, p. 89–98.
28. TAYLOR, CW., WANG, Z., MACAULAY, E., et al. Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013. Int J Radiat Oncol Biol Phys, 2015, 93, p. 845–853.
29. STICK, LB., YU, J., et al. Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys, 2017, 97, p. 754–761.
30. XU, N., HO, MW., ZUOFENG, LI., et al. Can Proton Therapy Improve the Therapeutic Ratio in Breast Cancer Patients at Risk for Nodal Disease? Am J Clin Oncol, 2014, 37, p. 568–574.
31. LOMAX, AJ., CELLA, L., WEBER, D., et al. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys, 2003, 55, p. 785–792.
32. TOMMASINO, F., DURANTE, M., D’AVINO, V., et al. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery. Acta Oncologica, 2017, 56, p. 730–736. doi:10.1080/0284186X.2017.1299218
33. FLEJMER, AM., CHEHRAZI, B., JOSEFSSON, D., et al. Impact of physiological breathing motion for breast cancer radiotherapy with proton beam scanning – An in silico study. Phys Med, 2017, 39, p. 88–94.
34. ÖDÉN, J., TOMA-DASU, I., ERIKSSON, K., et al. The influence of breathing motion and a variable relative biologicl effectiveness in proton therapy of left-sided breast cancer. Acta Oncol, 2017, p. 1–9.
35. MADURO, JH. Future options: the potential role of proton irradiation. Breast. 2019;48 Suppl 1:S76–S80. doi:10.1016/S0960-9776(19)31129-4
    
36. HAAS, A., ANDRLÍK, M., AL-HAMAMI, S., PÁSZTOROVÁ, A. Proveditelnost, dozimetrické hodnocení a časné výsledky protonové radioterapie v léčbě bilaterálního karcinomu prsu. Onkologie, 2022, 16(5); 258-262: https://www.ptc.clinic/wp-content/uploads/2022/11/Proveditelnost-dozimetricke-hodnoceni-a-casne-vysledky-protonove-radioterapie-v-lecbe-bilateralniho-karcinomu-prsu-1.pdf
37. PÁSTOROVÁ, A., HAAS, A., AL-HAMAMI, S., ABRAHÁMOVÁ, J., KUBEŠ, J., ONDROVÁ, B., ANDRLÍK, M., ŠIMÁNKOVÁ, D. Protonová radioterapie – dozimetrické výhody při ozařování pacientek s karcinomem prsu. Praktický lékař, 2024, 104(2): 84–92: Protonová radioterapie – dozimetrické výhody při ozařování pacientek s karcinomem prsu